FDA — authorised 30 December 1988
- Marketing authorisation holder: LIEBEL-FLARSHEIM
- Status: approved
🇺🇸 Optiray 320 in United States
FDA authorised Optiray 320 on 30 December 1988
Marketing authorisations
FDA — authorised 29 May 1998
- Application: NDA020923
- Marketing authorisation holder: LIEBEL-FLARSHEIM
- Local brand name: OPTIRAY 320
- Indication: INJECTABLE — INJECTION
- Status: approved
Optiray 320 in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Hematology approved in United States
Frequently asked questions
Is Optiray 320 approved in United States?
Yes. FDA authorised it on 30 December 1988; FDA authorised it on 29 May 1998.
Who is the marketing authorisation holder for Optiray 320 in United States?
LIEBEL-FLARSHEIM holds the US marketing authorisation.